US biotech start-up Aurora Therapeutics has launched with $16 million in seed funding from Menlo Ventures, aiming to turn one ...

Menlo Ventures has made a $16 million bet that the “ baby KJ ” custom CRISPR therapy success story is repeatable. The funding ...

Evaxion Biotech A/S (EVAX) has made significant progress thus far in advancing a few candidates in its pipeline. That's because it is currently testing the use of EVX-01 in an ongoing phase 2 study ...

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...

On Saturday, the Stanford Students in Biodesign and Biopharma (SSB) hosted “Impulse,” among Stanford’s premier biotechnology conferences, bringing together a community of students building products ...

Evaxion Biotech A/S has extended the duration of its phase 2 trial for the personalized cancer vaccine EVX-01 from two years to three years. This additional year aims to gather more extensive clinical ...

One of the biggest, if not the biggest, trend in drug development today focuses on the fast-approaching era of personalized medicines. We are quickly shifting from an age of blockbusters to new ...

Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person’s body. It promises to revolutionize healthcare making ...

External funding is imperative for biotech growth. Larger public biotech companies are a significant source of capital for the sector. So, too, is venture capital. In 2018, venture capital funding for ...